Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel for Ovarian Stromal Tumors
NCT00006227Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Nov 2000
- Primary completion
- Jul 2016
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of Paclitaxel Micelles for Injection in ovarian stromal tumor, sponsored by GOG Foundation. Primary endpoints: Probability of Complete Clinical Response up to 5 years and Toxicity. Started Nov 2000; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
ovarian stromal tumor
Beyond the preview
Go deeper on NCT00006227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006227.